UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stability of chitosan-a challenge for pharmaceutical and biomedical applications

Marine Drugs, 2015-04, Vol.13 (4), p.1819-1846

2015

Volltextzugriff (PDF)

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine

Clinical and experimental allergy, 2021-06, Vol.51 (6), p.861-863

2021

Volltextzugriff (PDF)

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines

Molecular therapy, 2021-03, Vol.29 (3), p.898-900

Moghimi, S. Moein

2021

Volltextzugriff (PDF)

γ-Cyclodextrin

International journal of pharmaceutics, 2017-01, Vol.516 (1-2), p.278-292

2017

Volltextzugriff (PDF)

The activities of drug inactive ingredients on biological targets

Science (American Association for the Advancement of Science), 2020-07, Vol.369 (6502), p.403-413

2020

Volltextzugriff (PDF)

Immune‐mediated adverse reactions to vaccines

British journal of clinical pharmacology, 2019-12, Vol.85 (12), p.2694-2706

2019

Volltextzugriff (PDF)

An Overview of Pharmaceutical Excipients: Safe or Not Safe?

Journal of pharmaceutical sciences, 2016-07, Vol.105 (7), p.2019-2026

2016

Volltextzugriff (PDF)

Formulation strategy and use of excipients in pulmonary drug delivery

International journal of pharmaceutics, 2010-06, Vol.392 (1), p.1-19

2010

Volltextzugriff (PDF)

Selecting appropriate excipients for paediatric dosage form − Paediatric excipients risk assessment (PERA) framework – Part 1

European journal of pharmaceutics and biopharmaceutics, 2024-10, Vol.203, p.114458, Article 114458

2024

Volltextzugriff (PDF)

Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

Advanced drug delivery reviews, 2013-11, Vol.65 (13-14), p.1828-1851

Sosnik, Alejandro

2013

Volltextzugriff (PDF)

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery

European journal of pharmaceutics and biopharmaceutics, 2015-04, Vol.91, p.82-90

2015

Volltextzugriff (PDF)

Recent advances in ocular drug delivery

Drug development and industrial pharmacy, 2013-11, Vol.39 (11), p.1599-1617

2013

Volltextzugriff (PDF)

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv126-iv142

2018

Volltextzugriff (PDF)

Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID‐19 vaccines: A systematic review and meta‐analysis

Allergy (Copenhagen), 2023-01, Vol.78 (1), p.71-83

2023

Volltextzugriff (PDF)

"Inactive" ingredients in oral medications

Science translational medicine, 2019-03, Vol.11 (483)

2019

Volltextzugriff (PDF)

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines

Journal of investigational allergology & clinical immunology, 2021-01, Vol.31 (1), p.92-93

2021

Volltextzugriff (PDF)

Risks of dairy derived excipients in medications for lactose intolerant and cow milk protein allergic patients

Scientific reports, 2024-07, Vol.14 (1), p.15631-7, Article 15631

2024

Volltextzugriff (PDF)

Inconsistent excipient listings in DailyMed: implications for drug safety

Naunyn-Schmiedeberg's archives of pharmacology, 2024-09, Vol.397 (9), p.6851-6854

2024

Volltextzugriff (PDF)

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Clinical pharmacokinetics, 2019-07, Vol.58 (7), p.827-833

2019

Volltextzugriff (PDF)

Solid lipid nanoparticles for parenteral drug delivery

Advanced drug delivery reviews, 2004-05, Vol.56 (9), p.1257-1272

2004

Volltextzugriff (PDF)

Hidden danger: maize starch excipient allergy

Medical journal of Australia, 2024-03, Vol.220 (4), p.184-185

2024

Volltextzugriff (PDF)

Adverse reactions to COVID‐19 vaccines: A practical approach

Clinical and experimental allergy, 2021-06, Vol.51 (6), p.770-777

2021

Volltextzugriff (PDF)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions

Annals of allergy, asthma, & immunology, 2022-02, Vol.128 (2), p.153-160

2022

Volltextzugriff (PDF)

Review of the basic and clinical pharmacology of sulfobutylether-β-cyclodextrin (SBECD)

Journal of pharmaceutical sciences, 2010-08, Vol.99 (8), p.3291-3301

2010

Volltextzugriff (PDF)

Hidden danger: maize starch excipient allergy

Medical journal of Australia, 2024-09, Vol.221 (5), p.285-286

2024

Volltextzugriff (PDF)

1 – 25 von 763

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(681)
Mit Volltextzugriff
(543)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(634)
Life Sciences & Biomedicine
(630)
Humans
(605)
Excipients - Adverse Effects
(349)
Pharmacology & Pharmacy
(281)
Male
(267)
Female
(251)
Excipients
(236)
Animals
(213)
Biological And Medical Sciences
(189)
Medical Sciences
(182)
Excipients - Chemistry
(175)
Adult
(154)
Middle Aged
(114)
Pharmacology. Drug Treatments
(112)
Excipients - Administration & Dosage
(92)
Allergy
(87)
Chemistry, Pharmaceutical
(86)
Dermatology
(74)
Rats
(74)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stability of chitosan-a challenge for pharmaceutical and biomedical applications

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines

γ-Cyclodextrin

The activities of drug inactive ingredients on biological targets

Immune‐mediated adverse reactions to vaccines

An Overview of Pharmaceutical Excipients: Safe or Not Safe?

Formulation strategy and use of excipients in pulmonary drug delivery

Selecting appropriate excipients for paediatric dosage form − Paediatric excipients risk assessment (PERA) framework – Part 1

Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery

Recent advances in ocular drug delivery

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID‐19 vaccines: A systematic review and meta‐analysis

"Inactive" ingredients in oral medications

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines

Risks of dairy derived excipients in medications for lactose intolerant and cow milk protein allergic patients

Inconsistent excipient listings in DailyMed: implications for drug safety

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Solid lipid nanoparticles for parenteral drug delivery

Hidden danger: maize starch excipient allergy

Adverse reactions to COVID‐19 vaccines: A practical approach

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions

Review of the basic and clinical pharmacology of sulfobutylether-β-cyclodextrin (SBECD)

Hidden danger: maize starch excipient allergy

Suchergebnisse filtern